Kamel Mamchaoui

5.0k total citations
94 papers, 3.3k citations indexed

About

Kamel Mamchaoui is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Kamel Mamchaoui has authored 94 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 15 papers in Cell Biology and 15 papers in Physiology. Recurrent topics in Kamel Mamchaoui's work include Muscle Physiology and Disorders (41 papers), RNA Research and Splicing (20 papers) and CRISPR and Genetic Engineering (14 papers). Kamel Mamchaoui is often cited by papers focused on Muscle Physiology and Disorders (41 papers), RNA Research and Splicing (20 papers) and CRISPR and Genetic Engineering (14 papers). Kamel Mamchaoui collaborates with scholars based in France, United Kingdom and Italy. Kamel Mamchaoui's co-authors include Vincent Mouly, Gillian Butler‐Browne, Anne Bigot, R.N. Cooper, Denis Furling, James P. Di Santo, Gisèle Bonne, Georges Saumon, Jerry W. Shay and Woodring E. Wright and has published in prestigious journals such as Nature, Science and Nucleic Acids Research.

In The Last Decade

Kamel Mamchaoui

90 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamel Mamchaoui France 37 2.6k 489 464 412 385 94 3.3k
Ralf Dressel Germany 32 2.5k 0.9× 300 0.6× 308 0.7× 513 1.2× 440 1.1× 107 4.1k
Tomo Šarić Germany 35 2.9k 1.1× 327 0.7× 279 0.6× 895 2.2× 264 0.7× 84 4.7k
Anna Starzinski‐Powitz Germany 39 2.0k 0.8× 491 1.0× 357 0.8× 502 1.2× 191 0.5× 98 4.9k
Denise Paulin France 35 3.0k 1.1× 400 0.8× 1.4k 3.0× 404 1.0× 276 0.7× 86 4.3k
Katsuya Kominami Japan 20 2.0k 0.8× 517 1.1× 357 0.8× 397 1.0× 145 0.4× 31 3.7k
Christian Pinset France 27 2.1k 0.8× 196 0.4× 304 0.7× 265 0.6× 210 0.5× 67 2.6k
Paolo Grumati Italy 32 2.7k 1.0× 236 0.5× 1.6k 3.4× 450 1.1× 737 1.9× 54 4.8k
Sheng Ding United States 35 3.4k 1.3× 156 0.3× 292 0.6× 597 1.4× 197 0.5× 73 4.5k
Ian Lyons Australia 21 3.0k 1.1× 187 0.4× 380 0.8× 675 1.6× 201 0.5× 29 3.9k
Régis Doyonnas United States 23 1.7k 0.7× 502 1.0× 340 0.7× 559 1.4× 226 0.6× 37 3.0k

Countries citing papers authored by Kamel Mamchaoui

Since Specialization
Citations

This map shows the geographic impact of Kamel Mamchaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Mamchaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Mamchaoui more than expected).

Fields of papers citing papers by Kamel Mamchaoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamel Mamchaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Mamchaoui. The network helps show where Kamel Mamchaoui may publish in the future.

Co-authorship network of co-authors of Kamel Mamchaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Kamel Mamchaoui. A scholar is included among the top collaborators of Kamel Mamchaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamel Mamchaoui. Kamel Mamchaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munain, Adolfo López de, et al.. (2025). Characterization of DMPK and MBNL1 expression in cell models of myotonic dystrophy: a platform for drug screening. PubMed. 2(3). ugaf023–ugaf023.
2.
Brocard, Julie, Kamel Mamchaoui, Norma B. Romero, et al.. (2024). Functional benefit of CRISPR-Cas9-induced allele deletion for RYR1 dominant mutation. Molecular Therapy — Nucleic Acids. 35(3). 102259–102259. 1 indexed citations
3.
Mamchaoui, Kamel, et al.. (2024). Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system. Scientific Reports. 14(1). 21238–21238. 1 indexed citations
4.
Martínez‐Piñeiro, Alicia, Jovan Pešović, Estefanía Cerro-Herreros, et al.. (2024). Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity. iScience. 27(6). 109930–109930. 4 indexed citations
5.
Benarroch, Louise, Kamel Mamchaoui, Anne Bigot, et al.. (2023). Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts. Cells. 12(15). 1995–1995. 3 indexed citations
6.
Bartkuhn, Marek, Stefan Günther, Carsten Künne, et al.. (2022). Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression. Nature Communications. 13(1). 4184–4184. 12 indexed citations
7.
Mamchaoui, Kamel, et al.. (2022). Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model. Cellular and Molecular Life Sciences. 79(8). 441–441. 9 indexed citations
8.
Heher, Philipp, Massimo Ganassi, Adelheid Weidinger, et al.. (2022). Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target. Redox Biology. 51. 102251–102251. 44 indexed citations
9.
Marchesi, Elena, Matteo Bovolenta, Massimo L. Capobianco, et al.. (2021). Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach. Molecules. 26(24). 7662–7662. 3 indexed citations
10.
Timpani, Cara A., Craig A. Goodman, Christos G. Stathis, et al.. (2020). Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy. Scientific Reports. 10(1). 1125–1125. 27 indexed citations
11.
Moulay, Gilles, Jeanne Lainé, Masayuki Nakamori, et al.. (2020). Alternative splicing of clathrin heavy chain contributes to the switch from coated pits to plaques. The Journal of Cell Biology. 219(9). 34 indexed citations
12.
Owens, Daniel J., Sophie Moog, Arnaud Ferry, et al.. (2020). Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth. International Journal of Molecular Sciences. 22(1). 306–306. 21 indexed citations
13.
Faroni, Alessandro, Adam J. Reid, Adam P. Lightfoot, et al.. (2019). <p>Simplified in vitro engineering of neuromuscular junctions between rat embryonic motoneurons and immortalized human skeletal muscle cells</p>. SHILAP Revista de lepidopterología. Volume 12. 1–9. 9 indexed citations
14.
McPhee, Jamie S., Tristan R. McKay, Lorna M. FitzPatrick, et al.. (2018). A functional human motor unit platform engineered from human embryonic stem cells and immortalized skeletal myoblasts. SHILAP Revista de lepidopterología. Volume 11. 85–93. 7 indexed citations
15.
Schwartz, Christine, Martina Fischer, Kamel Mamchaoui, et al.. (2017). Lamins and nesprin-1 mediate inside-out mechanical coupling in muscle cell precursors through FHOD1. Scientific Reports. 7(1). 1253–1253. 38 indexed citations
16.
Mamchaoui, Kamel, et al.. (2017). Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes. PLoS ONE. 12(7). e0181065–e0181065. 7 indexed citations
17.
Rich, Jeremy N., Adam Karoutas, Pavel Tarlykov, et al.. (2015). ZNF555 protein binds to transcriptional activator site of 4qA allele andANT1: potential implication in Facioscapulohumeral dystrophy. Nucleic Acids Research. 43(17). 8227–8242. 12 indexed citations
18.
Miro, Julie, Valérie Rofidal, Sonia Hem, et al.. (2015). FUBP1: a new protagonist in splicing regulation of the DMD gene. Nucleic Acids Research. 43(4). 2378–2389. 28 indexed citations
19.
Krom, Yvonne D., Julie Dumonceaux, Kamel Mamchaoui, et al.. (2012). Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic Patient. American Journal Of Pathology. 181(4). 1387–1401. 66 indexed citations
20.
Torrente, Yvan, M. Belicchi, Maurilio Sampaolesi, et al.. (2004). Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. Journal of Clinical Investigation. 114(2). 182–195. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralf Dressel Breakdown of academic impact, for papers by Tomo Šarić Breakdown of academic impact, for papers by Anna Starzinski‐Powitz Breakdown of academic impact, for papers by Denise Paulin Breakdown of academic impact, for papers by Katsuya Kominami Breakdown of academic impact, for papers by Christian Pinset Breakdown of academic impact, for papers by Paolo Grumati Breakdown of academic impact, for papers by Sheng Ding Breakdown of academic impact, for papers by Ian Lyons Breakdown of academic impact, for papers by Régis Doyonnas
Rankless by CCL
2026